[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA199900235A1 - Аморфные бензотиофены, способы получения и способы применения - Google Patents

Аморфные бензотиофены, способы получения и способы применения

Info

Publication number
EA199900235A1
EA199900235A1 EA199900235A EA199900235A EA199900235A1 EA 199900235 A1 EA199900235 A1 EA 199900235A1 EA 199900235 A EA199900235 A EA 199900235A EA 199900235 A EA199900235 A EA 199900235A EA 199900235 A1 EA199900235 A1 EA 199900235A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
obtaining
application
amorphous
benzothyphenes
Prior art date
Application number
EA199900235A
Other languages
English (en)
Other versions
EA002022B1 (ru
Inventor
Джордж В. Кафф
Арвинд Л. Таккар
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199900235A1 publication Critical patent/EA199900235A1/ru
Publication of EA002022B1 publication Critical patent/EA002022B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение предлагает аморфную форму соединения формулы (I) описания. Также предлагаются способы получения материала, а также способы его использования.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199900235A 1996-08-28 1997-08-22 Аморфные бензотиофены, способы получения и способы применения EA002022B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2483196P 1996-08-28 1996-08-28
PCT/US1997/014768 WO1998008513A1 (en) 1996-08-28 1997-08-22 Amorphous benzothiophenes, methods of preparation, and methods of use

Publications (2)

Publication Number Publication Date
EA199900235A1 true EA199900235A1 (ru) 1999-08-26
EA002022B1 EA002022B1 (ru) 2001-12-24

Family

ID=21822611

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199900235A EA002022B1 (ru) 1996-08-28 1997-08-22 Аморфные бензотиофены, способы получения и способы применения

Country Status (25)

Country Link
EP (1) EP0826682B1 (ru)
JP (1) JP2002514174A (ru)
KR (1) KR20000035941A (ru)
CN (1) CN1244124A (ru)
AR (2) AR009333A1 (ru)
AT (1) ATE234295T1 (ru)
AU (1) AU723987B2 (ru)
BR (1) BR9713176A (ru)
CA (1) CA2263175A1 (ru)
CO (1) CO4650039A1 (ru)
CZ (1) CZ64399A3 (ru)
DE (1) DE69719640T2 (ru)
EA (1) EA002022B1 (ru)
ES (1) ES2195089T3 (ru)
HU (1) HUP0001172A3 (ru)
IL (1) IL128641A (ru)
IN (1) IN182940B (ru)
NO (1) NO990914L (ru)
NZ (1) NZ333839A (ru)
PE (1) PE108598A1 (ru)
PL (1) PL333356A1 (ru)
TR (1) TR199900403T2 (ru)
WO (1) WO1998008513A1 (ru)
YU (1) YU10599A (ru)
ZA (1) ZA977617B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980033284A (ko) * 1996-10-30 1998-07-25 피터지.스트링거 개선된 유방암 예방법
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
FI982733A7 (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1832583A1 (en) * 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
US20050008704A1 (en) * 2003-07-11 2005-01-13 Ray Anup Kumar Pharmaceutical composition for solubility enhancement of hydrophobic drugs
US7803818B2 (en) * 2005-12-21 2010-09-28 Eisai R&D Management Co., Ltd. Amorphous form of 1,2-dihydropyridine compound
GB2456096B (en) 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
WO2011000581A2 (en) 2009-07-02 2011-01-06 Synthon B.V. Raloxifene composition
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
ITMI20121821A1 (it) * 2012-10-25 2014-04-26 Erregierre Spa Composizione farmaceutica solubile in acqua a base di un sale di raloxifene

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4230862A (en) * 1975-10-28 1980-10-28 Eli Lilly And Company Antifertility compounds
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5631369A (en) * 1994-08-31 1997-05-20 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
EP0826682B1 (en) 2003-03-12
IL128641A (en) 2001-10-31
EA002022B1 (ru) 2001-12-24
CA2263175A1 (en) 1998-03-05
TR199900403T2 (xx) 2002-01-21
CO4650039A1 (es) 1998-09-03
IL128641A0 (en) 2000-01-31
KR20000035941A (ko) 2000-06-26
CZ64399A3 (cs) 1999-05-12
AU4233597A (en) 1998-03-19
ATE234295T1 (de) 2003-03-15
JP2002514174A (ja) 2002-05-14
AR009333A1 (es) 2000-04-12
EP0826682A1 (en) 1998-03-04
BR9713176A (pt) 2000-02-08
IN182940B (ru) 1999-08-14
AR009334A1 (es) 2000-04-12
NZ333839A (en) 2001-06-29
CN1244124A (zh) 2000-02-09
ZA977617B (en) 1999-02-25
NO990914D0 (no) 1999-02-25
WO1998008513A1 (en) 1998-03-05
PE108598A1 (es) 1999-01-13
DE69719640D1 (de) 2003-04-17
DE69719640T2 (de) 2003-11-06
NO990914L (no) 1999-02-25
HUP0001172A2 (hu) 2001-06-28
ES2195089T3 (es) 2003-12-01
PL333356A1 (en) 1999-12-06
YU10599A (sh) 2001-07-10
AU723987B2 (en) 2000-09-07
HUP0001172A3 (en) 2002-01-28

Similar Documents

Publication Publication Date Title
EA199900643A1 (ru) Сульфамидные ингибиторы металлопротеаз
EA200100773A1 (ru) Замещенные 1-гетероциклические диариламины
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
EA199900620A1 (ru) Фталазиноны
EA199900381A1 (ru) Арил(тио)эфиры галогенпиримидина в качестве пестицидов
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
EA199700061A1 (ru) Способ получения силденафила
EA199900581A1 (ru) Производные индана или дигидроиндола
EA199900421A1 (ru) Бензонафтиридины в качестве бронхиальных терапевтических средств
EA200000239A1 (ru) Стимуляторы секреции гормона роста
EA199900326A1 (ru) Промежуточные соединения и способ получения оланзапина
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
EA200000094A1 (ru) Способ получения замещенного пергидроизоиндола
EA199900235A1 (ru) Аморфные бензотиофены, способы получения и способы применения
EA200000320A1 (ru) Изохинолины в качестве ингибиторов урокиназы
EA200000519A1 (ru) 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
EA200100854A1 (ru) Кальций-литические соединения
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
EA199800034A1 (ru) Способ получения n-монозамещенных и n,n'-дизамещенных асимметричных циклических мочевин
EA199800753A1 (ru) Бензотиофены, составы их содержащие и способы с их использованием
EA200000522A1 (ru) 5-htагонисты
EA199900534A1 (ru) Имидазопиридазины
EA200000520A1 (ru) 2-АРИЛ-3-АРОИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
EA199900241A1 (ru) ЗАМЕЩЕННЫЕ 1,2,3,4-ТЕТРАГИДРО-2-ДИБЕНЗОФУРАНАМИНЫ И 2-АМИНОЦИКЛОГЕПТА [b] БЕНЗОФУРАНЫ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU